Where are they now? Tracking down 2012's Fierce 15
Where are they now? Tracking down 2012's Fierce 15
In 2012, we profiled the biggest risk takers in biotech, narrowing our list down to 15 companies aiming to tackle hard-to-treat diseases and pioneering next-gen treatments. | It’s the 20th year we’ve sought out the most innovative private biotechs, which also means we’ve entered the second decade we’ve been checking in on our past honorees.
‘News of the Day’ content, as reported by public domain newswires.
Source Information (if available)
It appears the above article may have originally appeared on www.fiercebiotech.com and has been shared elsewhere on the internet, repeatedly. News articles have become eerily similar to manufacturer descriptions.
We will happily entertain any content removal requests, simply reach out to us. In the interim, please perform due diligence and place any content you deem “privileged” behind a subscription and/or paywall.
First to share? If share image does not populate, please close the share box & re-open or reload page to load the image, Thanks!